After that insane 20,000 cr. volume in Sun Pharma yesterday as Daiichi sold a whopping Rs. 20,000 cr. worth shares, who really bought them? Turns out the buyers weren’t named Dilip Shanghvi (the promoter of Sun Pharma). While we don’t know the identity of all other buyers, we do know from NSE’s Bulk Deals reporting that three big investors bought into Daiichi’s selling. Here they are: Temasek Aranda Investments, Mauritius is a subsidiary of Temasek , a Government of Singapore investment arm. 2.02 cr. shares Rs. 1,915 cr. Singapore Govt. The Goverment of Singapore also invested directly in the issue, and brought in over Rs. 1,000 cr. 1.26 cr. shares Rs. 1,197 cr. Goldman Sachs Goldman Sachs, Singapore also bought Daiichi’s holdings, with nearly 5,000 cr. invested in the issue. 5.12 cr. shares Rs. 4,864 cr. Note: We assume investments were made at Rs. 950. We will probably know of the others only if they bought more than 1% of the company or if they report these purchases elsewhere.… (Read On…)
[via Capital Mind]
Follow us @investmentheat – lists / @sectorheat